Company Filing History:
Years Active: 2017-2021
Title: Shantaram Pawar: Innovator in Parenteral Dosage Forms
Introduction
Shantaram Pawar is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of parenteral dosage forms. With a total of 3 patents to his name, his work has the potential to enhance the stability and efficacy of critical medications.
Latest Patents
One of his latest patents is for a parenteral dosage form of norepinephrine. This invention relates to a ready-to-administer aqueous solution of norepinephrine, which includes an anti-oxidant that is not a sulfite anti-oxidant. The dosage form is designed to remain stable at room temperature for an extended period. Another significant patent is for a parenteral dosage form of amiodarone. This invention provides a stable, sterile, ready-to-administer solution of amiodarone or its pharmaceutically acceptable salt. The formulation includes an acid and a polyol, with a pH range of about 2.0 to 4.0, and is filled in a plastic container without a solubilizer.
Career Highlights
Shantaram Pawar is currently associated with Sun Pharmaceutical Industries Limited, a leading pharmaceutical company. His work focuses on innovative solutions that improve the delivery and effectiveness of essential medications.
Collaborations
He has collaborated with notable colleagues such as Prashant Kane and Subhas Balaram Bhowmick, contributing to a dynamic research environment that fosters innovation.
Conclusion
Shantaram Pawar's contributions to the field of pharmaceuticals, particularly through his patents on parenteral dosage forms, highlight his role as an innovator. His work not only advances medical science but also has the potential to improve patient care significantly.